Isaac Manke

Insider Reports History

Location
New York, NY
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isaac Manke:

Company Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. Director Class A Common Stock 20,583 $61,749 $3.00 31 Dec 2025 Direct
Q32 Bio Inc. Director Stock Option (Right to Buy) 53,521 $35,254 $13.42 23 Oct 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7,650 28 May 2025 Direct

Insider Reports Filed by Isaac Manke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 31 Dec 2025 1 $0 4 Director 02 Jan 2026, 16:10
QTTB Q32 Bio Inc. 23 Oct 2025 1 $0 4 Director 27 Oct 2025, 21:26
OKUR OnKure Therapeutics, Inc. 30 Sep 2025 1 $0 4 Director 02 Oct 2025, 16:16
OKUR OnKure Therapeutics, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 16:26
OKUR OnKure Therapeutics, Inc. 28 May 2025 1 $0 4 Director 30 May 2025, 16:53
OKUR OnKure Therapeutics, Inc. 31 Mar 2025 1 $0 4 Director 02 Apr 2025, 16:37
QTTB Q32 Bio Inc. 15 Jan 2025 7 $0 4 Director 27 Feb 2025, 06:05
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 1 $0 4 Director 08 Oct 2024, 19:27
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 Director 08 Oct 2024, 19:11
QTTB Q32 Bio Inc. 01 Apr 2024 1 +$35,254 4 Director 30 Sep 2024, 06:01
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 Director 27 Mar 2024, 17:42
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 Director 27 Mar 2024, 17:24